Lariboisiere Hospital
Paris, 75010, France
NCT Number: NCT01080937
During the last decade, progress has been made in the management of heart failure. However, the changing characteristics of patients and practices in the "real world" and their impact on the prognosis of patients admitted for acute heart failure remain poorly studied.
2000 consecutive patients recruited in a single day in hospitals volunteered to participate in the cohort during a day dedicated.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75010, France
The total duration of recruitment is one day (date to be set soon by the Executive Committee): all patients hospitalized, and whatever their date of admission with the diagnosis of heart failure will be selected for the study.
Information on each hospital stay will be obtained at baseline and at the end of the hospitalization by the hospital teams.
A telephone follow-up will be conducted at 3 months among survivors and / or their doctor by CRAs dedicated to the French Society of Cardiology.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Analyze survival 3 months after the end of initial hospitalization
Time frame: 3 months
Compare methods of care based on clinical characteristics and hospital structures.
Time frame: 3 months
Analyze patterns of admission and discharge of patients, depending on their characteristics
Time frame: 3 months
Analyze the co-morbidities and their impact on care and survival
Time frame: 3 months
Analyze the evolution of drug treatment between the output and monitoring to 3 months
Time frame: 3 months
Analyze the use of resources specific diagnostic: measurement of BNP or NTproBNP, conducting echocardiogram, coronary angiography, Holter-ECG, Cardiac MRI, Cardiac CT
Time frame: 3 months
Analyze the use of therapeutic resources based on specific clinical features: intensive care, ventilation, inotropes, ultrafiltration, introduction of beta-blockers, stimulation, implantable cardioverter defibrillator, circulatory support, graft
Time frame: 3 months
Analyze the duration of stay according to clinical characteristics.
French Cardiology Society
Other
Acronym: OFICA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00561483
Acute Heart Failure, Female Urogenital Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT04886128
Acute Heart Failure, Cardiovascular Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT04363697
Acute Heart Failure, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05613218
Acute Heart Failure, Hypoxemia
Copenhagen, Denmark
View Trial Details